TAYLOR HICKS: Open Payments
NPI 1164115119 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,545 in 152 payments from 21 companies in 2025. Trend: 2023 $1,829 · 2024 $3,359 · 2025 $3,545
Food & beverage: $3,445Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $598 |
| Incyte Corporation | 16 | $503 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $478 |
| ABBVIE INC. | 27 | $415 |
| Lilly USA, LLC | 9 | $281 |
| GENZYME CORPORATION | 6 | $151 |
| PFIZER INC. | 6 | $137 |
| Regeneron Healthcare Solutions, Inc. | 2 | $136 |
| UCB, Inc. | 4 | $133 |
| MAYNE PHARMA COMMERCIAL LLC | 10 | $133 |
Products named: TREMFYA, OPZELURA, ILUMYA, SKYRIZI, EBGLYSS, RINVOQ, DUPIXENT, CIBINQO.
Industry payments across TX — which companies pay providers there.
